MTOR and liver cancer: Liu et al. study showed that targeting the MAPK pathway has additive and synergistic effects when with other pathways important for liver cancer cell proliferation, such as the mammalian target of rapamycin (mTOR) and Wnt/β-catenin pathways [21].